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Abstract
Transcription factor (TF)–induced reprogramming of somatic cells into induced pluripotent stem cells (iPSC) is associated
with genome-wide changes in chromatin modifications. Polycomb-mediated histone H3 lysine-27 trimethylation
(H3K27me3) has been proposed as a defining mark that distinguishes the somatic from the iPSC epigenome. Here, we
dissected the functional role of H3K27me3 in TF–induced reprogramming through the inactivation of the H3K27 methylase
EZH2 at the onset of reprogramming. Our results demonstrate that surprisingly the establishment of functional iPSC
proceeds despite global loss of H3K27me3. iPSC lacking EZH2 efficiently silenced the somatic transcriptome and
differentiated into tissues derived from the three germ layers. Remarkably, the genome-wide analysis of H3K27me3 in Ezh2
mutant iPSC cells revealed the retention of this mark on a highly selected group of Polycomb targets enriched for
developmental regulators controlling the expression of lineage specific genes. Erasure of H3K27me3 from these targets led
to a striking impairment in TF–induced reprogramming. These results indicate that PRC2-mediated H3K27 trimethylation is
required on a highly selective core of Polycomb targets whose repression enables TF–dependent cell reprogramming.
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Introduction
The realization that the expression of few transcription factors
can reassign cell fate has been a paradigm-shifting insight for
biology and medicine, from the pioneering conversion of
fibroblasts into myoblasts [1], to the achievement of inducing
pluripotency from adult somatic cells [2]. In particular, for the
derivation of induced pluripotent stem cells (iPSC), the enticing
medical opportunities during the past few years have focused most
efforts on improving the efficiency and safety of transcription
factor (TF)-induced reprogramming, and on defining the molec-
ular and functional equivalence between iPSC and embryonic
stem cells (ESC). Substantial progress has been made in the
characterization of distinct stages of the reprogramming process
(reviewed in [3]) as well as of its key features, such as the
mesenchymal-to-epithelial transition [4,5], and the importance of
cell-cycle progression [6–11]. Yet, in terms of molecular under-
standing, we still lack a mechanistic insight of how the somatic
gene expression program is silenced in order to enable the
reacquisition of the pluripotent state. In particular, the functional
relevance of defined chromatin modifications has only recently
started to be explored [12–15], especially as far as those histone
marks are concerned that orchestrate genome programming
during development.
Genome-wide analyses have started to provide a detailed
description of the chromatin changes that underlie TF-induced
reprogramming to pluripotency. The very initial stages of the
process entail the widespread acquisition of dimethylation of
lysine-4 of histone H3 (H3K4me2) at promoters and enhancers of
pluripotency genes that will be reactivated however only at later
stages, indicating that this modification primes but does not
directly trigger gene activation [16]. Conversely, analyses of
established iPSC at the end of the reprogramming process
revealed that changes in Polycomb-mediated trimethylation of
lysine-27 of histone H3 (H3K27me3) represent a key feature that
distinguishes the fibroblast from the iPSC epigenomes [17].
The Polycomb axis is organized around two families of protein
complexes, Polycomb Repressive Complex 1 (PRC1) and Poly-
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comb Repressive Complex 2 (PRC2) (reviewed in [18]). Both
contain enzymatic activities that catalyze, respectively, mono-
ubiquitylation of lysine-119 on histone H2A (H2AK119Ub)
(carried out by RING1B and, to a lesser extent, RING1A) and
di- and tri-methylation of lysine-27 of histone H3 (catalyzed by
EZH2 and, to a lesser extent, EZH1) [18]. H3K27me3 constitutes
a docking site for the chromodomain of CBX proteins, members
of PRC1, leading to a cascade model for Polycomb action, in
which PRC2 deposits H3K27me3 that then recruits PRC1 to
enable H2AK119Ub [18]. Gene silencing by PRC2 is required for
normal development and differentiation ([19] reviewed in [20]). In
the mouse, inactivation of Ezh2 or the essential non-enzymatic
components of the complex, SUZ12 and EED, results in severe
developmental failures in vivo and in varying degrees of impairment
during ESC differentiation in vitro [21–27]. Thus, the finding that
H3K27me3 constitutes the most significant chromatin mark that
distinguishes somatic from iPSC epigenomes supports the notion
that TF-induced reprogramming may represent the reverse
trajectory of normal development and posits for this mark a key
role in the repression of the somatic gene expression program.
Furthermore, a hallmark feature of the ESC epigenome, fully
shared with iPSC, is the presence of bivalent H3K4me3/
H3K27me3 chromatin domains [28,29]. These hold the promot-
ers of key developmental regulator genes in a plastic state of
minimal expression, poised for either full activation or definitive
repression in a lineage-specific manner. Ablation of PRC2
components in ESC leads to the misexpression of many of these
developmental targets [21,22], indicating that bivalency is a
critical feature of ESC pluripotency and predicting that its re-
establishment is a necessary condition in iPSC reprogramming.
Here we provide functional validation of the relevance of
H3K27me3 in the reacquisition of pluripotency, through the
conditional inactivation of Ezh2 resulting in bulk depletion of
H3K27me3 at the onset of TF-induced reprogramming. Our
results demonstrate that, surprisingly, global H3K27me3 is
dispensable for the reacquisition of the pluripotent state. Critically,
however, we find that upon Ezh2 inactivation, H3K27me3 is both
retained and de novo acquired on a specific core of Polycomb
targets involved in lineage determination and transcriptional
regulation. This highly selective silencing of the somatic gene
program is catalyzed by an alternative PRC2 and its inhibition
impairs reprogramming, thus uncovering a critical but highly
circumscribed role for H3K27me3 in TF-induced reprogram-
ming.
Results
Derivation of iPSC from mouse embryonic fibroblasts
upon Ezh2 inactivation
In order to investigate the function of H3K27 trimethylation
(H3K27me3) in TF-induced cell reprogramming, we derived
embryonic fibroblasts (MEF) from mutant mice harboring a
conditional Ezh2 knock-out allele carrying loxP sites (Ezh2fl)
flanking exons coding for the catalytic SET domain [30] (Figure 1
and Table 1). Experimental mice carried also an Oct4-GFP knock-
in reporter gene [31] to monitor endogenous Oct4 gene re-
activation during reprogramming. We expressed Oct4, Klf4, c-Myc
and Sox2 reprogramming factors from a single doxycycline-
regulated bicistronic lentiviral vector (STEMCCA), in which each
cistron codes for a fusion of two factors which are then released
through, respectively, F2A and E2A self-cleaving peptide signals
[32]. As depicted in Figure 1A, our reprogramming protocol
entailed: i) treatment of experimental (Ezh2fl/fl; Oct4-GFP) and
control (Ezh2+/fl; Oct4-GFP) MEF with cell-permeable TAT-Cre
recombinase to inactivate Ezh2; ii) infection with STEMCCA and
reverse tetracycline transactivator (rtTA) lentiviruses, followed by
replating at clonal density and switch to a chemically-defined
embryonic stem cell (ESC) medium (KSR) and administration of
doxycycline for 23 days; iii) withdrawal of doxycycline to select
cells that re-expressed the endogenous pluripotency factors; and iv)
isolation, clonal propagation and molecular and functional
characterization of individual iPSC clones. As controls, we used
interchangeably iPSC from Ezh2fl/+ MEF treated with TAT-Cre
(referred to as Ezh2DSET/+ iPSC) as well as iPSC from Ezh2+/+or
Ezh2fl/fl MEF that were not exposed to Tat-cre (referred to as
Ezh2+/+ and Ezh2fl/fl iPSC). Upon verification of comparable
efficiency in the infection with STEMCCA of control and mutant
MEF (Figure S1A), we analyzed the efficiency of reprogramming
following Ezh2 inactivation by comparing the number of primary
iPSC colonies assessed through staining with alkalyne phosphatase
(AP) 7 days after doxycycline removal (Figure 1B). Starting from
two different batches of MEF, we found no significant difference
in the number of iPSC colonies generated from mutant
(Ezh2DSET/DSET) and control (Ezh2DSET/+) fibroblasts (Figure 1B,
1C). As genome-wide chromatin analyses have postulated a critical
role for H3K27me3 in the resetting of transcriptional programs
during iPSC derivation [17], we tested whether this unexpected
finding resulted from selective reprogramming of Ezh2fl/fl MEF
that had escaped Cre-mediated recombination, thereby preserving
H3K27me3-dependent reprogramming proficiency. We ruled out
this possibility as the majority of iPSC clones analyzed carried the
SET-deleted Ezh2 allele regardless of the genotype (Figure S1B).
Representative iPSC clones of either genotype were analyzed by
Western blot and found to be devoid of functional EZH2 and with
undetectable H3K27me3 (Figure 1D). Levels of H3K27 dimethy-
lation (H3K27me2) were also decreased in mutant iPSC clones,
whereas H3K27 monomethylation (H3K27me1) remained unal-
tered (Figure 1D). Furthermore, global levels of the other major
repressive histone modification, histone H3K9 trimethylation
(H3K9me3), remained unaltered upon Ezh2 inactivation (Figure
S1C).
Author Summary
Multicellular organisms are composed of a variety of cell
types. Over the last years we have learned that cell
differentiation is fully reversible and that it takes few
specific transcription factors (proteins that bind to DNA
and regulate gene expression) to convert one cell type
into another. The most dramatic example is the repro-
gramming of somatic cells into stem cells that reacquire
the potential to give rise to all cell types of the body. This
process entails the resetting of the gene expression
program of the somatic cells necessary to acquire a
pluripotent state but remains poorly understood. Here, we
defined the role in cell reprogramming of the Polycomb
axis, one of the key effectors of gene silencing that
operates through a specific chemical modification of
histones (the trimethylation of lysine-27 on histone H3)
that is stably inherited from one cell generation to the
next. Surprisingly, we uncovered a selective requirement
for Polycomb silencing during somatic cell reprogram-
ming. Upon inactivation of the essential Polycomb protein
EZH2, histones trimethylated on lysine-27 were retained
on a selected subset of physiological Polycomb target
genes whose products control normal development, and
erasure of the histone mark from these critical genes
abolished reprogramming.
Selectivity of H3K27me3 in Cell Reprogramming
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Global loss of H3K27me3 was confirmed by high performance
liquid chromatography (HPLC) coupled to tandem mass spec-
trometry (MS/MS) analysis of the histone H3 fraction purified
from control and mutant iPSC clones. Specifically, we determined
the relative abundance of the peaks corresponding to the various
combinations of modifications harbored by the H3 peptide
spanning lysine-27 through arginine-40 (H327–40). A significant
change in the abundance and distribution of the various forms of
methylated H327–40 was observed (Figure 1E). We then carried out
a detailed MS/MS fragmentation analysis to pinpoint methylation
at specific residues, which indicated that H3K27me3 was
undetectable in Ezh2DSET/DSET iPSC clones, confirming that
changes in the relative abundance of methylated H327–40are
mainly attributed to loss of this modification (Table 1 and Figure
S1E).
Finally, we measured by qRT-PCR the expression levels, in
both mutant and control iPSC, of the exogenously provided
reprogramming factors, to exclude that reprogramming in the
absence of H3K27me3 had selected iPSC clones with a
pronounced leakiness of the doxycycline-inducible transgenes,
whose sustained expression enabled the maintenance of
H3K27me3-depleted iPSC. As shown in Figure S1D, we excluded
this possibility since EZH2-proficient and EZH2-deficient iPSC
showed equivalent, minimal levels of transgene expression
following doxycycline withdrawal.
Self-renewal and pluripotency of Ezh2DSET/DSET iPSC
Having determined that Ezh2 inactivation in MEF is compatible
with TF-induced cell reprogramming, we performed a compre-
hensive functional characterization of representative control and
mutant iPSC clones. Ezh2DSET/DSET and Ezh2DSET/+ control MEF
yielded iPSC colonies: i) with distinctive iPSC/ESC morphology
(Figure 2A, left panel), ii) that stained positive for AP (Figure 2A,
middle panel); and iii) that had reactivated the endogenous Oct4
gene (as assessed by GFP fluorescence, Figure 2A, right panel).
iPSC clones of either genotype had the same percentage of cells
Figure 1. Derivation and biochemical analysis of iPSC upon conditional Ezh2 inactivation. A. Diagram of the reprogramming protocol of
MEF. B. Alkaline phosphatase staining of control (lower row) and mutant (upper row) primary iPSC colonies one week following doxycycline
withdrawal. C. Number of AP-positive primary iPSC colonies obtained upon infection of, respectively, 26103, 56103, 16104 or 66104 MEF in two
experiments performed with two biological replicates per genotype. D. EZH2, H3K27me1, H3K27me2 and H3K27me3 protein levels assessed by
Western blot in two representative Ezh2 control (+/+) and mutant (DSET/DSET) iPSC clones. Vinculin and Histone H3 were used as loading controls for,
respectively, EZH2 and methylated forms of H3K27. E. Relative abundance in control (upper row) and mutant (lower row) iPSC clones of the six
possible methylation isoforms of the Histone H3 peptide spanning amino acids 27–40, as determined by mass spectrometry.
doi:10.1371/journal.pgen.1003292.g001
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co-expressing the pluripotency markers OCT4 and SSEA1, as
measured by flow cytometry (Figure 2B). Next we assessed control
and mutant iPSC clones for the two cardinal features that define
the pluripotent state: self-renewal and the ability to differentiate
into cell types of the three germ layers.
Self-renewal is currently best assessed by growing ESC and
iPSC under chemically defined conditions that entail the dual
inhibition (2i) of mitogen activated protein kinase (MAPK) and
glycogen synthase kinase 3 (GSK3) signaling, in the presence of
leukemia inhibitory factor (LIF) (commonly referred to as 2i/LIF
medium). These highly selective culture conditions were shown to
capture the ground state of pluripotency exhibited by cells of the
epiblast inner cell mass (ICM) [33]; importantly, they were also
shown to selectively promote the full reprogramming of partially
reprogrammed cells to the authentic pluripotent state [34]. As
shown in Figure 2C, Ezh2 mutant and control (Ezh2+/+) iPSC
clones grew readily in 2i/LIF and have been cultivated for over 20
passages. Finally, we tested the ability of Ezh2-proficient (Ezh2+/+)
and mutant (Ezh2DSET/DSET) iPSC to differentiate along the three
embryonic lineages through the formation of teratomas. iPSC
clones of either genotype (2 clones for each genotype) injected into
NOD/SCID Il2rcc2/2immunodeficient mice gave rise within
three to four weeks to teratomas harboring terminally differenti-
ated cell types derived from the three germ layers. Differentiation
was assessed combining hematoxylin/eosin with immunohisto-
chemical stainings for lineage-specific markers (desmin for the
mesodermal, S-100 for the neurectodermal and cytokeratin for the
endodermal and ectodermal lineages, respectively) (Figure 2D).
Next, we asked to which extent the transcriptome of Ezh2
mutant iPSC had been reset correctly during reprogramming. As
shown in Figure 2E and Figure S2, a stringent analysis of 4
independent control and mutant iPSC clones (t-test, FDR ,0.05)
revealed that transcriptomes were indistinguishable from each
other and equally divergent from MEF-specific ones. We validated
this result through qRT-PCR on a panel of well-established genes
associated with pluripotency, stemness and lineage specification (n.
7, 32 and 50 genes, respectively). Figure 2F shows a heat map
representation of the expression levels (expression data of all genes
are provided in Table S1), with iPSC clones of both genotypes
clustering together with ESC and sharply distinguished from MEF.
Bulk H3K27me3 is dispensable from the onset of
reprogramming
TAT-Cre-mediated inactivation of Ezh2 resulted in a threefold
decrease in global H3K27me3 levels by the onset of the
reprogramming process (Figure 3A). We therefore asked whether
the unexpected possibility to reprogram despite inactivation of
Ezh2 was due to residual H3K27me3 that could have still ensured,
during the very first days of reprogramming, a sufficient degree of
repression of lineage specific genes. To this end, we aimed at
erasing the H3K27me3 mark completely by dilution, through
serial passage of TAT-Cre treated MEF before the start of
reprogramming. In MEF, however, PRC2 is a direct repressor of
Cdkn2a, a locus encoding three key cell cycle regulators (p16, p19
and p15) whose activation promotes senescence [35]. Importantly,
expression of this locus, and in particular of p19/Arf, was shown to
hinder iPSC reprogramming [9], Thus, to prevent senescence
driven by Cdkn2a de-repression following Ezh2 inactivation (Figure
S3A), we resorted to compound primary tail tip fibroblasts (TTF)
harboring both the conditional Ezh2 allele and the Ink4/Arf knock-
out allele [36]. We subjected TTF to two sequential rounds of
TAT-Cre transduction and passaged them 5 times before infection
with STEMCCA and doxycycline administration (Figure 3B).
Following confirmation that H3K27me3 was undetectable by
Western blot on the day of infection with the reprogramming
lentivirus (Figure 3C), and that efficiency of infection was
equivalent for control and mutant TTF (Figure S3B), we went
on to measure the efficiency of TF-dependent reprogramming
under these most stringent conditions. As shown in Figure 3D, AP
staining revealed that TTF starting off with undetectable
H3K27me3 and controls yielded iPSC colonies with similar
efficiency. This indicates that bulk levels of H3K27me3 are not
required to prime silencing during the first days of reprogram-
ming.
Ezh2 depleted iPSC retain H3K27me3 on selected
Polycomb targets
The finding that bulk H3K27me3 was apparently dispensable
for reprogramming even when erased at the onset of the process
was at odds with its purported role as the critical mark that
distinguishes MEF from iPSC epigenomes as well as, more
broadly, with its pivotal role in the maintenance of gene repression
through embryogenesis and adulthood [17]. We therefore asked
whether, upon Ezh2 inactivation, residual levels of H3K27me3
below the threshold of Western blot and mass spectrometry
sensitivity, could still be deposited on selected targets. To address
this point we performed chromatin immunoprecipitation coupled
to high-throughput sequencing (ChIP-seq). We generated ChIP-
seq profiles from two independent control and mutant iPSC clones
for both H3K27me3 and H3K27me2 with highly specific
Table 1. Mass spectrometry analysis: H3K27me3 levels below the limit of detection in Ezh2DSET/DSET iPSCs.
Mascot Score* PTM Score**
Peptide Forms Modification Sites +/+ DSET/DSET +/+ DSET/DSET
me3 K27me3 48,72 ND 104,43 ND
me3 K27me1-K36me2 ND 38,55 ND 92,16
me3 K27me2-K36me1 52,3 20,02 117,35 32,14
me4 K27me2-K36me2 73,57 56,77 145,18 117,35
me4 K27me3-K36me1 47,61 ND 65,14 ND
me5 K27me3-K36me2 39,75 ND 92,16 ND
*Perkins et al 1999.
**Cox and Mann 2010.
Mascot and PTM scores attributed in control (Ezh2+/+) and mutant (Ezh2DSET/DSET) iPSC clones to each combination of amino acid modifications on the H327–40 tri-, tetra-
and penta-methylated peptide.
doi:10.1371/journal.pgen.1003292.t001
Selectivity of H3K27me3 in Cell Reprogramming
PLOS Genetics | www.plosgenetics.org 4 February 2013 | Volume 9 | Issue 2 | e1003292
Selectivity of H3K27me3 in Cell Reprogramming
PLOS Genetics | www.plosgenetics.org 5 February 2013 | Volume 9 | Issue 2 | e1003292
monoclonal antibodies. Consistently with our prediction, the
higher sensitivity of ChIP-seq did reveal the presence of residual
H3K27me3 in mutant iPSC clones. Specifically, the mark was
retained on 2477 genes (with an enriched region overlapping a +/
25kb region interval around the transcriptional start site, TSS),
comprising close to half of all H3K27me3 targets retrieved from
wild type iPSC. Mutant clones showed a preferential retention of
H3K27me3 proximal to the TSS of target genes. In comparison to
the full complement of PRC2 targets in control iPSC, mutant
clones displayed a clear tripartition in the genome-wide distribu-
tion of H3K27me3 and H3K27me2 marks (Figure 4A). 47% of
genes retained both H3K27me3 and H3K27me2, 39% of genes
were marked only by H3K27me2 and 13,7% of genes lost both
marks. Importantly, the complement of genes enriched for
H3K27me3 in mutant iPSC clones was almost entirely comprised
within the group of H3K27me3 targets found in control iPSC
cells, thus excluding a significant redistribution of the mark to new
targets in cells reprogrammed in the absence of functional Ezh2
(Figure 4B). Furthermore, we found only a small overlap in the
distribution of H3K27me2-only targets between control and
mutant iPSC clones. Instead, the complement of genes marked
only by H3K27me2 in mutant iPSC clones was to a good extent
comprised within the subset of genes that are H3K27 trimethy-
lated in control iPSC (Figure 4C). Thus, we conclude that during
reprogramming in the absence of Ezh2, i) H3K27me3 is selectively
retained on a subset of the targets that are normally H3K27
trimethylated in iPSC, where it coexists with H3K27me2; ii)
H3K27me2 is lost at targets that are normally carrying only this
mark in iPSC; and iii) H3K27me2 is retained in 86% of the targets
that are normally H3K27 trimethylated in iPSC, coexisting, in half
of these, with residual H3K27me3. We validated these findings
through individual ChIP-qPCR on genes selected among those
that were downregulated in the MEF to iPSC transition (Figure 4D
and Table S2). We confirmed the sharp distinction between a
group of genes that retained both H3K27me3 and H3K27me2
and those that only retained H3K27me2, irrespective of the level
of transcriptional repression that was equivalent for the two groups
between control and mutant iPSC (Figure 4D and Table S2).
Interestingly, we found a stronger enrichment for PRC2 on the
genes that selectively retained the H3K27me3 mark, likely
reflecting its ability to act as docking site for the EED subunit of
PRC2.
In the absence of EZH2, EZH1 is the only other known
enzymatic component of PRC2, where its enzymatic activity is
however twenty fold weaker than that of EZH2 [37]. Our findings
support therefore a model in which, in the presence of EZH1-only
PRC2 complexes, genes that are normally more enriched for
PRC2 will be more likely to accumulate H3K27me3 because they
will have a higher chance of having the weak activity of EZH1
result in productive trimethylation. In turn this will further
enhance PRC2 recruitment, establishing a feed-forward loop that
guarantees on selected targets residual levels of H3K27me3. We
tested this hypothesis by analyzing, in control iPSC, the average
enrichment for H3K27me3 in genes that, in mutant iPSC,
respectively retain or lose this mark. As shown in Figure 4E and
Figure S4B, genes that retain H3K27me3 in mutant iPSC showed
indeed a highly significant stronger enrichment for this mark in
control iPSC cells, both in terms of maximum height and average
read density (p-value,2.2e-16, two tailed t-Test). In almost all
cases however, targets that retain H3K27me3 in mutant iPSC also
feature H3K27me2 (contrary to what happens in control iPSC),
indicating that EZH1 does not reach H3K27 trimethylation: 1) in
all cells of the population, 2) on both alleles of the same cell, or 3)
on both histone H3 tails of the same nucleosome. The non-
randomness of H3K27me3 marking in mutant iPSC was
confirmed by the virtually identical genome-wide distribution of
H3K27me3 and H3K27me2 in two independent iPSC mutant
clones (Figure S4D), as well as by the striking similarity between
the distributions of, respectively, H3K27me3 in control and
H3K27me2 in mutant iPSC (Figure S4C).
Targets of H3K27me3 in Ezh2 mutant iPSC are enriched
for transcriptional regulators and developmental
determinants
Finally, we asked whether the H3K27me tripartition of the
mutant iPSC epigenome identified functionally relevant classes of
genes. To this end we analyzed the three groups of PRC2 targets
differentially methylated in mutant iPSC (H3K27me3+/
H3K27me2+; H3K27me32/H3K27me2+; and H3K27me32/
H3K27me22) in terms of the Gene Ontology (GO) of their
members (Figure 4F). Remarkably, the subset of genes that
retained H3K27me3 in mutant iPSC showed a distinct GO profile
when compared to the other two classes, with a clear enrichment
for categories linked to development, cellular differentiation and
transcriptional regulation. This unique signature was confirmed
when the GO enrichment in H3K27me3-retaining genes was
probed against the sole complement of all Polycomb targets,
further underscoring the functional partition of the Polycomb
epigenome. The H3K27me32/H3K27me2+ and H3K27me32/
H3K27me22 subsets were instead strongly enriched for genes
involved in metabolic homeostasis and cellular transport.
Remarkably, while genes that retained H3K27me3 in mutant
iPSC comprised 47% of the physiological PRC2 epigenome, they
were disproportionately enriched for genes preferentially ex-
pressed in MEF versus iPSC (comprising 69,2% of the total,
Figure 4G). This suggested that retention of H3K27me3 in Ezh2
mutant iPSC occurred on selected targets to enable silencing of the
MEF-specific gene expression program. Specifically, we found 550
genes, among those that retained H3K27me3 in mutant iPSC,
Figure 2. Characterization of pluripotency in iPSC clones reprogrammed upon Ezh2 inactivation. A. Images of phase contrast (left),
alkaline phosphatase staining (middle) and Oct4-driven GFP fluorescence (right) of representative control (Ezh2+/DSET, upper row) and mutant
(Ezh2DSET/DSET, lower row) iPSC colonies. B. Flow cytometric analysis of SSEA-1 and endogenous OCT4 (OCT4-GFP) levels in representative control
(Ezh2+/DSET, upper row) and mutant (Ezh2DSET/DSET, lower row) iPSC clones (cl.1 and cl.2). Embryonic stem cells (ESC) were used as positive control for
SSEA1 expression (upper left). C. Growth curve of representative control (Ezh+/+, grey) and mutant (Ezh2DSET/DSET, purple) iPSC clones cultured in 2i/LIF
medium for the indicated hours. Column height represents cell number. D. Hematoxylin & eosin staining and immunohistochemical analysis of
representative sections of teratomas generated from either Ezh2 control (Ezh2+/+) or mutant (Ezh2DSET/DSET) iPSC cells of two representative clones.
Stainings for mesoderm (upper row), endoderm (middle row) and ectoderm (lower row) markers are displayed. Data displayed in A, B, C and D are
representative of at least four independent experiments, using two iPSC clones per genotype. E. Scatter plots showing global gene expression
correlation analyses between Ezh2+/+ and Ezh2DSET/DSET iPSC (left panel), Ezh2+/+ iPSCs and MEF (central panel) and Ezh2DSET/DSET iPSC and MEF (right
panel). Correlation coefficients (r) reveal the degree of similarity for each comparison. Genes within red lines differ less than 1.5-fold. F. Heat map
representation of expression levels of genes involved in pluripotency, stemness and differentiation in two control (Ezh2+/+, first and second column)
and two mutant (Ezh2DSET/DSET, third and fourth column) iPSC clones. ESC (fifth column) and MEF (last column) were used for comparison. Colors
range from yellow (low dCt, higher expression) to black (high dCt, lower expression). Hierarchical clustering of samples is also shown.
doi:10.1371/journal.pgen.1003292.g002
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that were downregulated in the MEF to iPSC transition (Figure
S5A). Among these, 175 acquire H3K27me3 de novo in the MEF to
iPSC transition and are enriched in GO categories related to
transcriptional regulation (Figure S5B). We hypothesized the
presence within this group of one or more MEF-specific master
regulators that were silenced during reprogramming through
H3K27me3. We thus performed a master regulator analysis
(MRA) to identify the TFs whose targets (predicted on the basis of
their consensus binding sites) are over-represented in the
differentially expressed genes (DEGs) between MEF and iPSC.
To this end we applied the transcription factor binding site over-
representation analysis algorithm [38]. This analysis uncovered
four TFs, Egr1, Ets1, Prxx1, Prxx2, whose binding sites were
significantly over-represented (FDR,5%) among the 175 DEGs
that acquire de novo H3K27me3 in the transition from MEF to
iPSC, and are predicted to control the bulk (84%) of the up-
regulated genes in MEF with respect to iPSC (Figure S5C).
Notably, expression of Egr1 and Ets transcript levels showed a
strong reduction within the first week of reprogramming,
corroborating their role in the silencing of the MEF-specific
program (Figure S5D).
PRC2 catalyzes residual H3K27 trimethylation in Ezh2
mutant iPSC
Previous reports have highlighted partial redundancy between
Ezh2 and Ezh1 in several cell types [27,39]. To determine whether
an alternative PRC2 complex is responsible for H3K27me3 of
target genes also in Ezh2-mutant iPSC, we knocked down the
essential PRC2 component EED in Ezh2-mutant iPSC. Infection
of two Ezh2-mutant iPSC clones with lentiviruses expressing two
independent shRNAs against Eed promoted a substantial reduction
of EED protein levels (Figure 5A). Ezh2-mutant iPSC stably
interfered for Eed (or infected with a control virus) were subjected
to ChIP-qPCR assays on a representative set of target genes
retaining the H3K27me3 mark in mutant iPSC. As shown in
Figure 5B, levels of H3K27me3 decreased substantially in two
independent Ezh2-mutant iPSC clones upon Eed knock-down.
Importantly, loss of H3K27me3 led to the reactivation of target
gene expression (Figure 5B, right panel). These results indicate
that an alternative EZH1-containing PRC2 complex deposits
H3K27me3 on a selected subset of Polycomb targets during
reprogramming of Ezh2-mutant iPSC, to promote stable gene
repression.
Given the existence of an alternative PRC2 complex that
functions in Ezh2 mutant iPSC, we determined the effect of Eed
knock-down on TTF reprogramming. Specifically, Ezh2-proficient
Cdkn2a2/2 TTFs were infected first with a lentivirus expressing a
shRNA against Eed, and few days later with the STEMCCA
reprogramming virus (Figure S6A). As control, TTF cells were
infected first with a control virus followed by STEMCCA.
Quantification of iPSC colonies by AP staining performed two
weeks after the beginning of doxycycline treatment revealed an
over 80% reduction in reprogramming efficiency upon Eed
inactivation (Figure 5E), indicating that PRC2-mediated
H3K27me3 deposition on a selected subset of Polycomb targets
is necessary for correct fibroblast reprogramming.
Discussion
Trimethylation on lysine-27 of histone H3 by Polycomb
proteins has been characterized as a critical mechanism that
ensures the cell-type specific establishment and maintenance of
gene silencing in multicellular organisms [19,20,40,41]. From ESC
to tissue-specific stem cells, this chromatin mark has been
associated to the timed repression of developmental regulator
genes, which underlies in turn the physiological unfolding of cell
fate transitions [19–22,42–44]. Consistent with its role in the
physiology of genome programming during development, the
Polycomb axis has been hypothesized as a key player in the
reprogramming of somatic cells epigenomes. In particular TF-
induced reprogramming, through its relatively high efficiency
coupled with the stability of the reprogrammed state and the
ability to study defined stages of the process, enabled the first
Figure 3. Establishment of iPSC clones upon genome-wide
erasure of H3K27me3 at the onset of reprogramming. A.
Western blot analysis of EZH2 and H3K27me3 protein levels respectively
at onset or 48 hr after reprogramming in Ezh2+/DSET and Ezh2DSET/DSET
MEFs. Data are representative of two experiments. Quantification of
protein levels at the indicated time points is shown in the right panel
(controls in grey, mutants in purple). B. Strategy to induce reprogram-
ming of tail tip fibroblasts (TTFs) lacking H3K27me3 at the onset of
reprogramming. C. Western blot analysis of EZH2 and H3K27me3
protein levels in Cdkn2a2/2 TTF carrying either one (+/DSET) or both
(DSET/DSET) Ezh2 mutant alleles. As comparison, representative Ezh2-
proficient (+/+) and -deficient (DSET/DSET) iPSC clones were analyzed.
The band corresponding to H3K27me3 in mutant TTF has the same
intensity of that from a mutant iPSC clone for which mass-spectrometry
did not detect the presence of H3K27me3. D. Quantification of AP-
positive primary iPSC colonies obtained from infection of 2.56103
Cdkn2a2/2 TTF, respectively proficient (grey bar) or deficient (purple)
for Ezh2, assessed in three independent experiments.
doi:10.1371/journal.pgen.1003292.g003
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insight into the chromatin changes that underlie cell fate
reassignment on a genome-wide scale. Among 16,500 promoters
that were analyzed by ChIP-on-chip, roughly 1000 differed
sharply in the H3K4me3 and H3K27me3 status when MEF were
compared to ESC [17]. Nearly all of these signature genes
displayed H3K4me3 and H3K27me3 patterns that were identical
between ESC and iPSC, thus providing the first evidence that the
transition from MEF to iPSC recapitulated, in addition to the
transcriptome, to a large extent also the epigenome of ESC.
Importantly, however, a comparison of methylation maps between
MEF, ESC and iPSC revealed that H3K4me3 changed consid-
erably less between the three cell types than H3K27me3, whose
distribution was instead remarkably different between MEF, on
the one hand, and ESC and iPSC on the other. This observation
suggested that changes in H3K27me3 were more relevant to
reprogramming than those in H3K4me3, and led to posit for the
Polycomb pathway a central role in the conversion of MEF into
iPSC [17]. A similar approach was used to investigate the earliest
stages of the reprogramming process, uncovering the acquisition of
H3K4 dimethylation (H3K4me2) at several pluripotency loci and
developmental regulators that precedes their transcriptional
activation [16]. More recently the inactivation of the H3K27
demethylase UTX revealed the essential role of H3K27 demeth-
ylation in TF-induced reprogramming, through the reactivation of
a handful of pluripotency genes during the initial stages of the
process [13]. Similarly, Polycomb affected the ability of ESC to
reassign fate in cell fusion-based short term reprogramming [45].
Thus, while these data reveal the importance, in the early phase of
reprogramming, of the reactivation of the pluripotency network
through widespread H3K4me2 acquisition and loss of H3K27
methylation, the relevance of H3K27 trimethylase activity in
silencing somatic gene expression remains still ill defined.
Here we provide functional validation for the role of
H3K27me3 in TF-induced reprogramming. Our findings reveal
that functional inactivation of EZH2, the main catalyst of H3K27
trimethylation within PRC2, is surprisingly compatible with TF-
cell reprogramming. In its absence, reprogramming proceeds
through the deposition of H3K27me3 by the alternative EZH1-
PRC2, on a highly selected core of Polycomb targets controlling
lineage determination and transcriptional regulation. Moreover,
our data show that correct reprogramming requires an exquisitely
low amount of H3K27me3 below the limit of detection of mass
spectrometry. Bioinformatics analysis of ChIP-seq data revealed
that H3K27me3 is retained in Ezh2 mutant iPSC on about 2500
genes, representing close to half of all PRC2 targets in iPSC and
ESC. These include 2190 genes that are already marked by
H3K27me3 in MEF, with the remaining ones acquiring the
modification during the MEF to iPSC transition, thus indicating
that residual PRC2 is able through cell division to both propagate
the mark at pre-existing loci and redistribute it to new targets. The
correct reprogramming guaranteed by selective retention of
H3K27me3 was also consistent with the normal differentiation
of Ezh2-mutant iPSC in teratoma assays, defining the core subset
of functionally relevant Polycomb targets. Similar results were
obtained also when Ezh2 was inactivated in established iPSC (data
not shown). These data exclude a functional difference between
iPSC reprogrammed ab initio in the absence of Ezh2 or acutely
depleted of the enzyme following reacquisition of pluripotency. In
turn, this is consistent with the observation that H3K7me3 is
partially retained upon Ezh2 inactivation.
Importantly, fully independent mutant iPSC clones were indis-
tinguishable in their patterns of residual H3K27me3, indicating that
retention of the mark either follows an instructive mechanism or, if
stochastic, is subjected to a strong selection pressure that limits the
range of residual targets. The former possibility appears more likely
on the basis of two related observations: first, that residual
H3K27me3 targets in mutant iPSC are preferentially associated to
CpG islands, and second, that these residual H3K27me3 targets also
correspond to genes with higher levels of H3K27me3 in normal
iPSC. Combined, these evidences suggest that the basic mode of
PRC2 recruitment is conserved in Ezh2-mutant cells, allowing
prevalent targets to recruit enough mutant PRC2 for EZH1 to
catalyze productive H3K27 trimethylation.
In mutant iPSC, further inhibition of PRC2 through knock-
down of its critical subunit EED resulted in loss of H3K27me3 and
re-expression of developmental regulator genes, indicating that
maintenance and/or de novo acquisition of H3K27me3 is critical to
ensure silencing of the MEF-specific gene expression program.
Consistently, Eed knock-down in MEF prevented reprogramming.
This result highlights the essential contribution of H3K27me3 to
the repression of developmental regulator genes that enables
successful cell fate reassignment.
Materials and Methods
Mice
Ezh2fl, OCT4-GFP and Cdkn2a2/2 mice have been previously
described [30,31,36]. Compound mutants were generated inter-
crossing individual strains. Primers used for genotyping are listed
in Table S5.
Derivation of primary MEF and TTF
MEF were produced from E13.5 compound mutants following
standard procedures. Briefly, embryos were harvested from
pregnant females and MEF were isolated by enzymatic dissocia-
tion of tissues. Cells were cultured in MEF medium (DMEM high-
glucose, 10% fetal calf serum, 2mM L-glutamine, 50 units/ml
penicillin, 50 mg/ml streptomycin) at 37uC, 5% CO2 for up to
Figure 4. Genome-wide distribution of H3K27me3 in Ezh2DSET/DSET iPSC revealed through ChIP–seq. A. Pie chart showing partition of
Polycomb targets based on H3K27 methylation status in Ezh2DSET/DSET iPSCs. B. Venn diagram displaying overlap between H3K27me3+ genes in
Ezh2+/+ (grey) and Ezh2DSET/DSET (purple) iPSC. C. Venn diagram showing overlap between H3K27me3+ genes in Ezh2+/+ iPSC (grey), H3K27me2+/
H3K27me32 genes in Ezh2DSET/DSET iPSC (orange) and H3K27me2+/H3K27me32 in Ezh2+/+ iPSC (light blue). D. Analysis of transcript levels measured
by qRT-PCR, and status of SUZ12 binding, H3K27me2 and H3K27me1 enrichment revealed by ChIP q-PCR at promoters of 7 genes overexpressed in
MEF relative to iPSC and representative of groups of genes marked by either H3K27me2+/H3K27me3+ or H3K27me2+/H3K27me32 in Ezh2DSET/DSET
iPSC. For all analyses, two Ezh2 control (+/+; grey) iPSC clones were compared to two mutant (DSET/DSET; purple) counterparts. Levels of expression
are shown as ddCt (log2 scale) relative to MEF. Status of a particular histone modification (6SEM) is represented as fold change of enrichment relative
to input, after normalization for H3 density within the same amplicon. SUZ12 enrichment at promoters of indicated genes was determined
comparing it to that of an unrelated IgG. Error bars refer to qPCR triplicates. E. Average reads distribution of H3K27me3 around the TSS in Ezh2+/+
iPSC. Genes were divided in two classes based on H3K27me3 status in Ezh2DSET/DSET iPSC (H3K27me3+ genes in green, H3K27me32 genes in red) and
compared to all genes (black) F. Gene ontology analysis of genes belonging to the three main groups based on H3K27 methylation status in
Ezh2DSET/DSET iPSC depicted in panel A. Bars represent P-values in –Log2 scale of the corresponding biological processes. Dashed lines identify the
significance threshold. G. Pie chart of H3K27 methylation status in Ezh2DSET/DSET iPSC of MEF specific genes marked by H3K27me3 in Ezh2+/+ iPSC.
Color code is shown in panel A.
doi:10.1371/journal.pgen.1003292.g004
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passage-3 before TAT-Cre transduction and/or infection with
reprogramming viruses. For the preparation of adult tail tip
fibroblasts (TTF), 0.5 cm tail tips from 8 to 16-weeks old
compound mutants were biopsied aseptically, subjected to
enzymatic dissociation and cultured in MEF medium at 37uC,
5% CO2 for one week.
Figure 5. Effect of PRC2 inactivation on established Ezh2DSET/DSET iPSC clones and TF–induced reprogramming. A. Western blot analysis
of EED protein levels in two Ezh2DSET/DSET iPSC clones infected with control virus (empty) or lentiviruses expressing independent short hairpin (sh)
RNAs targeting Eed (#19 and #21)(left). Quantification of EED protein levels in infected cells after normalization based on Vinculin levels (right). B.
H3K27me3 status (left panel) and expression levels (right panel) measured respectively by ChIP-qPCR and qRT-PCR, of 4 representative genes up
regulated in MEF relative to iPSC, in two Ezh2DSET/DSET iPSC clones. Ezh2-mutant iPSC were infected with viruses expressing two independent hairpins
for Eed or with a control virus. Status of H3K27me3 (6SEM) is represented as enrichment relative to input, after normalization for H3 density within
the same amplicon. Expression levels are shown as fold change relative to iPSC infected with the empty vector. Error bars refer to qPCR triplicates. C.
Western blot analysis of EED and H3K27me3 protein levels at day-6 of puromycin selection on Cdkn2a2/2 Ezh2-proficient TTF expressing three
independent Eed hairpins (lines 1, 2 and 3) or infected with a control virus (line 4). Quantification of protein levels relative to Vinculin or Histone H3
are shown in the right panel. D. AP staining of primary iPSC colonies obtained upon reprogramming of 16103 (upper panel) Cdkn2a2/2 Ezh2-
proficient TTF expressing three independent Eed hairpins (lines 1, 2 and 3) or infected with an empty lentiviral vector (line 4) used as control. E.
Quantification of AP+ iPSC colonies. Column height represents number of AP+ iPSC colonies obtained from 16103 TTF expressing either one of the
three independent Eed hairpins (lines 1, 2 and 3) or infected with an empty lentivirus vector (line 4) as control. Data are representative of two
independent experiments performed using three different shRNAs.
doi:10.1371/journal.pgen.1003292.g005
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Lentivirus production
Lentiviral constructs coding for doxycycline-inducible
STEMCCA, reverse tetracycline transactivator (rtTA) and the
Zs-green reporter gene have been previously described [32].
Production of lentiviral particles was performed as previously
described [32]. Briefly, plasmids expressing viral proteins GAG,
POL, REV, TAT, and the vesicular stomatitis virus envelope
glycoprotein (VSV-G) were co-transfected with either STEMCCA
or rtTA vectors into semi-confluent 293T cells by calcium
phosphate precipitation in the presence of 25 mM chloroquine.
Supernatant of transfected cells were collected every 12 hours
during 2 consecutive days and concentrated by centrifugation.
Viral particles were resuspended in MEF medium and either used
freshly for infection or frozen at 280uC.
Infection of MEF and derivation of Oct4-GFP; Ezh2fl iPSC
MEF at passage 1 to 3 carrying either one (control) or both
(mutant) Ezh2 floxed alleles were seeded at a density of 26105
cells/well in a 6-well tissue culture dish. 24hr later, MEF were
transduced in a 1:1 PBS/DMEM/GlutaMAX (Invitrogen) solu-
tion with 50 mg/ml of recombinant TAT-Cre recombinase [46].
16 hour after transduction, medium was replaced, and MEF were
infected with the STEMCCA and rtTA lentiviruses. 24 hours
following infection with STEMCCA and rtTA, MEF were
harvested and seeded at clonal density on a mytomycin-treated
MEF feeder layer. One day after, MEF medium was replaced with
ESC medium (high glucose DMEM, 15% knockout serum
replacement-Invitrogen-, 2 mM L-glutamine, 50 units/ml peni-
cillin, 50 mg/ml streptomycin, 0,1 mM non-essential amino acids,
1/500 home-made leukaemia inhibitory factor, 0,1 mM 2-b-
mercaptoethanol) supplemented with 1 mg/ml doxycycline to
induce expression of the reprogramming factors. Doxycycline
treatment was replaced every other day for 23 days. Four days
after doxycycline withdrawal, iPSC colonies were stained for
alkaline phosphatase (AP), counted to assess the efficiency of
reprogramming or picked and expanded on a mitomycin-treated
MEF feeder layer to establish individual iPSC clones. To measure
the efficiency of infection, an aliquot of MEF of each genotype was
infected in parallel with a combination of STEMCCA, rtTA and a
lentivirus expressing ZsGreen under the EF1a´ constitutive
promoter. Three days after infection, cells were analyzed by flow
cytometry to assess the efficiency of infection. Established iPSC
clones were grown in 2i/LIF medium (DMEM/F-12+GlutaMAX,
Neurobasal Medium, N2 Supplement-Invitrogen-, B27 supple-
ment-Invitrogen-, 1,5 mM Hepes, 2 mM Glutammine, 0,1 mM
b-mercaptoethanol,1/500 home-made LIF, 3 mM CHIR99021,
1 mM PD0325901.
Infection of TTF and derivation of Cdkn2a2/2; Ezh2fl iPSC
Control Cdkn2a2/2Ezh2fl/+ and experimental Cdkn2a2/2Ezh2fl/fl
TTFs at passage-1 were treated with 50 ug/ml of TAT-Cre
recombinase and passaged 3 days later. At 80% confluency, cells
underwent a second round of TAT-Cre transduction and were
further expanded to allow the dilution of H3K27me3, before
infection with STEMCCA and rtTA lentiviruses, as described above.
RNA interference
Puromycin-resistant lentiviral constructs expressing Eed shRNAs
were purchased from Open Biosystem (TRCN0000095719,
TRCN0000095721, TRCN0000095722). Lentiviruses were pro-
duced as described above. Cdkn2a2/2 TTFs were infected with
viruses expressing either shRNA # TRCN0000095719,
TRCN0000095721, TRCN0000095722 or an empty pLKO.1
vector and selected with 2 mg/ml of puromycin. After 6 days of
selection, resistant TTFs were reprogrammed by infection with
Tet-STEMCCA as described above. Ezh2DSET/DSET iPSC clones
were infected with viruses expressing either shRNA #
TRCN0000095719, TRCN0000095721 or as control, an empty
pLKO.1 vector and expanded for two weeks in 0.7 mg/ml of
puromycin. RNA, proteins and chromatin were collected on the
same day.
Alkaline phosphatase staining
Alkaline phosphatase staining was performed using the Leuko-
cyte Alkaline Phosphatase kit (Sigma Aldrich) following manufac-
ture’s instructions.
Flow cytometry
One million cells were stained with phycoerythrin-conjugated
anti-mouse/human SSEA1 (eBioscience, 12-8813) in FACS buffer
(1% bovine serum albumin (BSA), 0,05% NaN3 in PBS), washed
and acquired on a FACS Calibur instrument (BD Biosciences).
Data were analyzed using FlowJo software (Tree Star inc.).
Teratoma assay
iPSC were cultured in 2i/LIF medium for 3 passages. 26106
cells were injected subcutaneously into NOD-SCID Il2ra˜c2/2
mice. 2–3 weeks after injection, mice were sacrificed and tumors
were isolated and fixed in 4% formaldehyde for immunohisto-
chemistry.
RNA extraction and cDNA synthesis
RNA was extracted using TRIzol Reagent (Invitrogen) and
purified with RNeasy mini kit (QIAGEN) following manufactur-
er’s instructions. cDNA was prepared using SuperScript VILO
cDNA Synthesis Kit (Invitrogen) following manufacturer’s instruc-
tions.
Quantitative gene expression analysis
Quantitative real-time PCR analysis for the expression of
fibroblast specific genes on MEF, 2 Ezh2+/+ iPSC clones, 2
Ezh2DSET/DSET iPSC clones, and 1 E14tg2a´ ESC line was performed
using pre-designed Taqman gene expression assays following
manufacturer’s instructions. (Applied Biosystems: Cd14Mm
00438094_g1, Cebpa Mm00514283_s1, Dok1 Mm00438532_m1,
Emp2 Mm00801709_m1, Enpp1 Mm00501097_m1, Fads3 Mm
00517643_m1, Bmp1Mm00802220_m1, Ndrg1 Mm00440447_m1,
Snai2 Mm00441531_m1, Sox9 Mm00448840_m1, Tram1l1, Mm
00525200_s1, Vamp5 Mm00444144_m1, Bmp1 Mm00802220_m1,
Cap2 Mm00482645_m1, Vcan Mm01283063_m1, Ptprm
Mm00436095_m1, Lox Mm00495386_m1, Pftk1 Mm
00448111_m1). Quantitative real-time PCR analysis for the expres-
sion of the STEMCCA vector was performed using a custom-
designed Taqman gene expression assay, previously described [32].
cDNA arrays
iPSC were cultured in 2i/LIF medium for 3 passages before
RNA extraction. Expression was assessed using the TaqMan Stem
Cell Pluripotency Array (Applied Biosystem 4385363) following
the manufacturer’s instructions. dCT values were calculated
subtracting each single CT value to the geometrical mean of the
housekeeping genes (Actb, Raf1, Ctnnb1, Gapdh and Eef1a1).
Hierarchical clustering and heat map were obtained using Gene
Cluster 3.0 software (Michael Eisen, Copyright 1998–99 Stanford
University; Michiel de Hoon, 2002 University of Tokyo, Human
Genome Center).
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Microarray analysis
Microarray analysis was performed on 4 Ezh2+/+ iPSC clones, 4
Ezh2DSET/DSET iPSC clones, 3 independent preparation of MEFs
and one sample of E14tg2a ESC using Affymetrix Mouse Gene
1.0 ST arrays. Labeling, hybridization, and washing were
performed according to Affimetrix guidelines. Data analysis was
performed with R software version 2.15.0 (http://www.r-project.
org) starting from raw data (CEL files). Data were normalized
using robust multichip analysis (RMA) algorithm [47] as
implemented in [48] and made available through Bioconductor
(http://www.bioconductor.org/). To perform differential expres-
sion analysis, we started from the log2 normalized value relative to
each gene. Then, we used a t-test to identify significant changes in
gene expression between wild type and mutant samples, and a P
value was calculated for each gene. A false discovery rate (FDR)
procedure [49] was applied to take into account multiple testing
correction. To identify differentially expressed genes (DEGs) we
considered a threshold of 0.05 on the corrected P value, along with
a cut-off of 1.5-fold changes.
Gene Ontology analysis
We used Cytoscape software [50] and the BiNGO plugin [51]
to analyze Gene Ontology terms significantly enriched in the
various gene sets. The enrichment for each term was tested using
hypergeometric test and P values were corrected using FDR
procedure. All terms with a FDR,0.01 were considered enriched.
Protein extraction and Western blot analysis
iPSC were cultured in 2i/LIF medium for 3 passages before
protein extraction. Cell pellets were lysed with urea buffer (8 M
Urea, 0,1 M NaH2PO4, 0,01 M Tris base diluted in water,
pH 8.0) at room temperature for 30 minutes on a rotating wheel.
Lysates were sonicated with a Bioruptor Sonication System
(UCD200) (3 cycles of 30 seconds with one minute breaks, high
power). Lysates were centrifuged at 13000 rpm for 15 minutes and
supernatants were transferred to a new tube. Protein quantifica-
tion was performed using Bio-Rad protein assay and following
manufacturer’s instructions. For the detection of histone modifi-
cations 40 mg of total protein extracts were loaded into a 12%
acrylamide gel. For the measurement of EZH2 levels, 80 mg of
total protein lysates were loaded onto an 8% acrylamide gel.
Western blot was performed using standard procedures. Intensities
of Western blot bands were determined using ImageJ software
(rsbweb.nih.gov/ij/). Antibodies used for Western blot are listed in
Table S3.
Mass spectrometry
A detailed description of core histone extraction and mass
spectrometry analysis can be found in Text S1.
Histology and immunohistochemistry
Teratoma tissues were washed in PBS buffer for 30 minutes,
fixed in 4% buffered formalin for 4 hours and paraffin embedded.
Samples were processed in consecutive 3 mm thick sections and
stained with haematoxylin and eosin. Immunostaining for desmin,
protein S-100 and cytokeratin were performed using an automated
immunostainer (Autostainer, DakoCytomation, Glostrup, Den-
mark) and a commercially available detection kit (DakoEnVision
Plus-HRP), according to the manufacturer’s instructions. Detailed
information about antibodies and immunostaining procedure are
listed in Table S4. After immunostaining, sections were counter-
stained with 1% modified Harris hematoxylin, dehydrated and
mounted. Standard reference positive and negative controls were
run simultaneously. Haematoxylin and eosin and immunohisto-
chemistry images were taken with an Olympus Upright BX 51
optical microscope equipped with a Nikon digital color camera.
Digital images were processed with Adobe Photoshop CS3.
Chromatin immunoprecipitation
iPSC cultured in 2i/LIF medium were trypsinized and
resuspended in 1% formaldehyde/PBS solution. Cross-linking
was allowed to proceed for 10 min at room temperature and
stopped by addition of glycine at a final concentration of 0.125 M,
followed by an additional incubation for 5 min. Fixed cells were
washed twice with PBS and resuspended in SDS buffer (SDS
0.5%, Tris-Cl pH 8.1 50 mM, NaCl 100 mM, EDTA pH 8
5 mM, NaN3 0.02%, diluted in ddH2O) and stored at 280uC.
SDS cell suspensions were thawed at room temperature using a
water bath for 20 minutes, centrifuged at 2000 rpm and
resuspended in ice cold IP buffer (SDS buffer/Triton dilution
buffer = 2:1; Triton dilution buffer: Triton X-100 5%, Tris-Cl
pH 8.6 100 mM, NaCl 100 mM, EDTA pH 8 5 mM, NaN3
0.02%, diluted in ddH2O). Fixed cells were sonicated yielding
genomic DNA fragments with a bulk size of 400 to 1000 bp.
Sonicated material was centrifuged at 13000 rpm for 30 minutes
at 4uC and supernatants were transferred into a new tube.
Chromatin was quantified using Bio-Rad protein assay following
manufacturer’s instructions. For immunoprecipitation using anti-
bodies against H3 and specific histone modifications, 100 mg of
chromatin were used. For immunoprecipitation of SUZ12, 500 mg
of chromatin were used. For each immunoprecipitation assay,
chromatin was diluted in 1 ml IP buffer and 10 ml were taken and
stored at 280uC as 1% of input. Primary antibodies were
incubated overnight at 4uC on a rotating platform. To each
sample, 50 ml of 50% slurry of protein A-Sepharose (Amersham)
beads were added for 2–3 h. Beads were washed three times in
150 mM wash buffer and one time in 500 mM wash buffer
(Triton-X 1%, NaCl 150 mM or 500 mM, Tris-Cl pH 8.0
20 mM, SDS 0.1%, EDTA pH8 2 mM diluted in water). Beads
(and input samples) were resuspended in 120 ml of 0.1% SDS,
0.1 M NaHCO3 buffer and de-cross-linked at 65uC overnight.
DNA was purified using PCR purification kit (QIAGEN) following
the manufacturer’s instruction and eluted in 100 ml of water. 1 ml
of eluted material was used for each real-time quantitative PCR
(qPCR) reaction. Quantitative real-time PCR analysis was
performed in triplicate using Fast SYBR Green master mix
(Applied Biosystems) in a 7500 Fast Real-Time PCR instrument
(Applied Biosystems). Antibodies used for ChIP are listed in Table
S3. Primers used for ChIP-qPCR are listed in Table S5.
ChIP–seq
ChIP-seq analysis was performed on two Ezh2 +/+ iPSC clones
and two Ezh2DSET/DSET iPSC clones. 10 ng of sheared DNA
obtained before (input) and after chromatin IP using anti-
H3K27me3 and -H3K27me2 specific antibodies, were prepared
with the Illumina ChIPSeq sample prep kit and multiplexing
oligonucleotide kit. DNA libraries were quantified using a high
sensitivity Chip on Bioanalyzer (Agilent) and diluted to a
concentration of 16 pM. Diluted libraries were used for cluster
generation and sequencing on a HiSeq 2000 instrument (Illumina)
following manufacturer’s protocol.
Bioinformatics analysis of ChIP–seq data
Mapping of reads. After filtering for artifacts with FASTX-
Toolkit v.0.0.13, reads were aligned to the mm9 genome using
Bowtie v.0.12.7 [52], allowing up to two mismatches per read and
discarding multiply-aligning reads. Each ChIP-seq experiment had
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a total of 18 to 28 millions of uniquely mapped reads. Aligned
reads of a MEF H3K27me3 ChIP-seq dataset were downloaded
from the Gene Expression Omnibus (accession id GSM656316)
and processed similarly to the other datasets (see below).
Identification of enriched domains. We used two different
strategies to identify enriched domains using, respectively, MACS
v.1.4.0 [53] and RSEG v.0.4.8 [54]. For MACS analysis, we
disabled the shifting model and the dynamic lambda (which are
inappropriate for histone modifications) and used a stringent p-
value threshold of 10e-10. A more generous identification of
enriched regions was done using RSEG, which was specifically
designed to identify extended regions marked by histone marks
(RSEG was independently benchmarked in [55]). We used
Hideaki’s empirical method to determine bin size, 20 iterations
for the training, and provided deadzones (regions where no read
can map uniquely) as described in the documentation. Domains
called as unconfident were discarded. In both approaches, we
compared the signal over the input.
On the basis of a calibration performed in ESC and of
biological and technical considerations (see Text S1 for further
details), we applied the MACS method to identify H3K27me3
enriched genomic regions, while RSEG was used to identify
domains of enriched H3K27me2.
Annotation. For both H3K27me3 and H3K27me2, we
assigned enriched regions to genes by determining for each
RefSeq transcript, whether an enriched domain overlapped with a
+/25 kb region around the transcription start site. We also tested
a +/22.5 kb interval, which resulted in a marginal decrease in the
number of gene annotations. Transcripts were then collapsed to
gene symbols using BioMart [56], and only the genes marked in
both biological replicates (Figure S4D) were retained for further
analysis.
Heat map and clustering of H3K27me3 and H3K27me2
distributions around the TSS were produced with Seqminer [57]
using K-means linear normalization.
Venn diagrams showing overlap between different datasets were
prepared using BioVenn (by Tim Hulsen http://www.cmbi.ru.nl/
cdd/biovenn/).
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Supporting Information
Figure S1 Molecular and biochemical characterization of Ezh2
mutant iPSC clones. A. Flow cytometric analysis of Ezh2 control
(+/DSET, upper row) and mutant (DSET/DSET, lower row)
MEF infected with STEMCCA, rtTA and GFP-expressing
lentiviruses in two replicate experiments (left and right panel).
MEF are gated according to cell size (FSC) and GFP expression.
Numbers within dot plots indicate percentage of gated cells. B.
Table indicating the status of the Ezh2 floxed allele in individual
iPSC clones isolated upon reprogramming of TAT-Cre trans-
duced Ezh2fl/+ and Ezh2fl/fl MEF. Numbers of iPSC clones of the
indicated Ezh2 genotypes and total number of isolated clones are
shown. C. Western blot analysis of H3K9me3 levels in embryonic
stem cells (ESC), control (+/+ and DSET/+) and mutant (DSET/
DSET) iPSC (two clones/genotype). H3 levels were used as control
for protein loading. D. Transcription from the STEMCCA vector
as revealed by qRT-PCR in representative control (n = 4) and
mutant (n = 3) iPSC clones. Measurements are relative to
STEMCCA transcript levels detected in infected MEF treated
for 10 days with doxycycline. Uninfected MEF were used as
negative control. Standard deviations refer to replicates of the q-
PCR reaction. E. Annotated MS/MS spectra of H3 peptide 27–40
species, with one or more co-existing post-translational modifica-
tions detected in Ezh2 control (+/+; left spectra) and mutant
(DSET/DSET) iPSC. Spectra are displayed according to whether
the peptide contained a total of 3 (upper row), 4 (middle row) or 5
(lower row) methyl groups. The m/z ratio of b- and y- product
ions identified are annotated in the spectrum and also reported
along the amino acid sequence in blue and red, respectively.
(TIF)
Figure S2 Identification of MEF specific genes by cDNA
microarray analysis. Heat map representation of the average
expression profile of MEF coming from 3 different embryos, 4
Ezh2 control (+/+) iPSC clones and 4 Ezh2 mutant (DSET/DSET)
iPSC clones. Shown are the expression levels of 3644 genes
differentially expressed between iPSCs and MEFs (p-value = 0.05;
f.c = 1.5). Expression ranges from lower (green) to higher levels
(red).
(TIF)
Figure S3 Establishment of iPSC clones upon genome-wide
erasure of H3K27me3 at the onset of reprogramming. A.
H3K27me3 and p16Ink4a protein levels measured by Western
blot analysis in representative populations of TAT-cre transduced
Ezh2 control (+/DSET) and mutant (DSET/DSET) MEF after two
passages and 11 days of culture. As comparison, representative
control (+/+) and mutant (DSET/DSET) iPSC clones were
analyzed. Vinculin protein levels were used as loading control.
B. Flow cytometric assessment of the infection efficiency of Ezh2
control (Ezh2DSET/+; right columns) and mutant (Ezh2DSET/DSET,
left columns) Cdkn2a2/2 TTFs (3 independent batches/genotype).
Cells were infected with STEMCCA, rtTA and GFP expressing
lentiviruses. Numbers within plots indicate percentage of gated
cells.
(TIF)
Figure S4 Epigenetic characterization of Ezh2DSET/DSET iPSCs.
A. Analysis of transcript levels (qRT-PCR) and status of PRC2
(SUZ12), H3K27me2 and H3K27me1 (ChIP q-PCR) enrichment
at promoters of 17 genes overexpressed in MEF vs. iPSC. For all
analyses, two Ezh2 control (+/+; grey) iPSC clones were compared
to two mutant (DSET/DSET; purple) counterparts. Levels of
expression are shown as ddCt (log2 scale) relative MEF. Status of a
particular histone modification (6SEM) is represented as enrich-
ment relative to input, after normalization for H3 density within
the same amplicon. SUZ12 enrichment at promoters of the
indicated genes is assessed comparing it to that of unrelated IgG.
Error bars referred to qPCR triplicates. B. Distribution of the
maximum height of H3K27me3 signal in Ezh2+/+ iPSC according
to H3K27me status in 2 Ezh2DSET/DSET iPSC clones: genes that
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lose H3K27me3 (red lines), genes that retain H3K27me3 (green
lines). P-value,2.2e-16 (two-sided t-test). C. Heat map represen-
tation of H3K27me3 and H3K27me2 distributions in a 65 Kb
window around the TSS of genes marked by at least one of the two
methylation states. Data from 2 representative clones per genotype
are shown Regions were inverted depending on the direction of
transcription. Genes were clustered according to the combination
of the two marks. D. Venn diagrams showing overlap of
H3K27me3 targets (upper row) or H3K27me2 targets (lower
row) between 2 iPSC clones of the same genotype (Ezh2 +/+ left;
Ezh2DSET/DSET right).
(TIF)
Figure S5 Targets of H3K27me3 in Ezh2 mutant iPSC are
enriched for transcriptional regulators and developmental deter-
minants. A. Tree diagram representing the main steps that lead to
the identification of 175 genes that acquired H3K27me3 de novo in
the MEF to iPSC transition. See main text for further explanation.
B Gene ontology analysis of de novo H3K27 trimethylated genes in
the MEF to iPSC transition. Bars represent P values in –Log2 scale
of the corresponding biological process. Dashed line indicates
significance threshold. C. Network showing protein-DNA inter-
actions (blue lines) between genes that change expression upon
reprogramming (blue circles) and the four identified master
regulators of fibroblast expression program (yellow circles). D.
qRT-PCR analysis of Ets1 and Egr1 transcript levels at day 0, day
3, day 6, day 10 and day 14 of MEF reprogramming. mRNA
levels are normalized to Tbp. Error bars represents qPCR
triplicates.
(TIF)
Figure S6 TF–induced reprogramming in the absence of PRC2.
A. Experimental time line showing the main experimental steps:
Infection of Ezh2 proficient Cdkn2a2/2 TTFs with control virus
(empty) or lentiviruses expressing independent short hairpin (sh)
RNAs targeting Eed; puromycin selection; Infection with Tet-
STEMCCA and rtTA lentiviruses; replating of infected cells at
cloning dilution and addition of ESC medium supplemented with
doxycycline; Doxycycline withdrawal and scoring of AP-positive
colonies.
(TIF)
Table S1 qRT-PCR analysis of transcript levels in two
representative Ezh2+/+ (# 40A7 and # 40A8) and
Ezh2DSET/DSET(# 48B4 and # 48B7) iPSC clones, of a selected
list of genes controlling stem cell pluripotency, self renewal and
differentiation. Transcript levels were also measured in ESC and
MEF. Data are represented as dCts relative to the geometric mean
of 5 housekeeping genes.
(XLSX)
Table S2 qPCR results of H3, H3K4me3, H3K27me3,
H3K27me2, and H3K27me1 ChIP on promoters of 17 MEF-
specific genes in two representative Ezh2 control (+/+, grey bars)
and mutant (DSET/DSET, purple bars) iPSC clones. Data are
represented as fold change of input. The same analysis was
performed using unrelated IgG for the ChIP assays. Averages and
standard deviation refers to qPCR triplicates.
(XLSX)
Table S3 List of antibodies used for Western blot, ChIP, and
flow cytometry.
(DOCX)
Table S4 List of antibodies used for immunohistochemistry.
(DOCX)
Table S5 List of primers used for ChIP–qPCR and genotyping.
(DOCX)
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